Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

IDEC-C2B8 development update

March 15, 1996

Virogenetics cancer vaccine in phase I/II trials

March 15, 1996

New antimitotic drugs from Pharmacia & Upjohn

March 15, 1996

European clinical trial results with irinotecan reported

March 15, 1996

PK1 to enter phase II

March 15, 1996

MEN-10746 selected for development

March 15, 1996

MEN-10755 named as candidate for clinical study

March 15, 1996

Inex reports on liposomal vincristine development

March 15, 1996

University of Bradford reports on cytotoxic indoloquinone

March 15, 1996

Distamycin analogue from P&U shows cytotoxic effects

March 15, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 9, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Medline plans record-setting $5.37B IPO
BioWorld MedTech
Almost a year since first filing its S-1 to return to public markets, Medline Inc. revealed the price range for the most awaited IPO of 2025. The massive medical...